News und Analysen
Sartorius: Wie hoch denn noch?
Wussten Sie eigentlich, dass auch Sartorius (WKN: 716563) zu den Überlebenden des Neuen Marktes zählt? Wenn nicht, dürften Sie sich in guter Gesellschaft befinden.
Denn selbst diejenigen, die
Vifor Pharma and Cara Therapeutics sign US license agreement for i.v. Korsuva™* to treat dialysis patients with pruritus
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005725/en/
Vifor Pharma and Cara Therapeutics, Inc
Evotec: Nach Abu Dhabi nun Bill Gates an Bord!
Evotec (WKN: 566480) meldet heute eindrucksvolle News mit Promifaktor. So wird Bill Gates – der Microsoft-Nerd, über den Elon Musk jüngst in Anspielung auf Michael Jacksons Hit "Billie Jean" sagte
Charles River Laboratories Adds George Llado to Board of Directors
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of George Llado, Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals, Inc., to
Premier Inc. Contracts with HHS on Data-Driven Initiative to Improve U.S. Maternal Health
Premier Inc. (NASDAQ: PINC) today announced a new, two-year, $8 million national partnership with the U.S. Department of Health and Human Services (HHS) Office of Women’s Health to leverage
Xencor to Present Data from the Phase 1 Study of XmAb®20717 and Three Research Programs at the SITC Annual Meeting
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced four poster
Premier, Inc. to Report Fiscal 2021 First-Quarter Results and Host Conference Call on November 2, 2020
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2021 first quarter on Monday, November 2, 2020, at approximately 4:15 p.m. ET. The company will
QIAGEN veröffentlicht starke vorläufige Zahlen für das dritte Quartal 2020
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gibt vorläufige Zahlen für Umsatz und bereinigtem Gewinn pro Aktie für das dritte Quartal 2020 bekannt.
Der Nettoumsatz stieg sowohl zu
QIAGEN reports strong preliminary results for third quarter of 2020
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today preliminary sales and adjusted earnings per share (EPS) results for the third quarter of 2020.
Net sales grew 26% at actual
Charles River Laboratories Schedules Third-Quarter 2020 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2020 financial results on Thursday, October 29th, before the market opens. A conference call has been scheduled
LivaNova präsentiert auf der Jahrestagung der European Association for Cardio-Thoracic Surgery neue Daten zur Demonstration der Vorteile der nahtlosen Percevalklappe
LivaNova PLC (NASDAQ:LIVN), ein marktführendes Medizintechnik- und Innovationsunternehmen, gab heute neue Daten aus der klinischen Studie über Perceval®, dem nahtlosen Implantat im Vergleich zum
Evotec: Jetzt ist auch Abu Dhabi an Bord
Wie das Hamburger Biotechnologieunternehmen Evotec (WKN: 566480) heute früh vermeldete, investieren die Mubadala Investment Company sowie die Novo Holdings 250 Millionen Euro im Rahmen einer
LivaNova Confirms Receipt of Letter from PrimeStone Capital
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today confirmed receipt of a letter from PrimeStone Capital LLP (PrimeStone) to its Board of Directors and
Chemed To Report Third-Quarter 2020 Earnings October 29, Related Conference Call To Be Held On October 30
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2020, on Thursday, October 29, 2020, following the close of trading on
LivaNova Presents New Data at European Association for Cardio-Thoracic Surgery Annual Meeting Demonstrating Benefits of Perceval Sutureless Valve
LivaNova PLC (NASDAQ:LIVN) a market-leading medical technology and innovation company, today announced new data from the Perceval® Sutureless Implant Versus Standard-Aortic Valve Replacement
AMN Healthcare to Host Third Quarter 2020 Earnings Conference Call on Thursday, November 5, 2020
AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, has scheduled a conference call to discuss its third quarter 2020
AMN Healthcare Announces Pricing of Senior Notes Offering
AMN Healthcare Services, Inc. (NYSE: AMN) announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $350.0 million aggregate
QIAGEN vervollständigt COVID-19 Testportfolio mit neuem Test-Kit zur Vereinfachung und Beschleunigung von PCR-Analysen in der Forschung
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, einen neuen optimierten Ansatz auf dem Gebiet der Epidemiologie von RNA-Viren einführen zu wollen, durch den die PCR-Analyse
QIAGEN to Complement COVID-19 Testing Portfolio With Novel Kit That Simplifies and Accelerates PCR Analysis for Research Applications
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to launch a novel straightforward approach to viral RNA epidemiology that will significantly simplify and accelerate PCR
AMN Healthcare Names Rear Admiral Sylvia Trent-Adams to Board of Directors
AMN Healthcare (NYSE:AMN) announces the appointment to its Board of Directors of Rear Admiral Sylvia Trent-Adams, PhD, RN, FAAN, a distinguished leader in the U.S. Public Health Service
Xencor Presents Initial Data From the Phase 1 Study of Tidutamab in Neuroendocrine Tumors at NANETS’ Multidisciplinary NET Medical Virtual Symposium
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced initial data
Novocure to Report Third Quarter 2020 Financial Results
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the third quarter 2020 on Thursday, October 29, 2020, before the U.S. financial markets open. Novocure’s management
Acadia Healthcare Announces Pricing of $475 Million Senior Notes Due 2029
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its previously announced private offering (the “Offering”) of $475 million in aggregate
Acadia Healthcare Announces Launch of $475 Million Senior Notes Offering
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of senior notes due 2029 (the “Notes”), subject